Antidepressants and public health in Iceland: Time series analysis of national data
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Major depressive disorder is the second leading cause of disability-adjusted life-years in developed regions of the world and antidepressants are the third-ranking therapy class worldwide. Aims: To test the public health impact of the escalating sales of antidepressants. Method: Nationwide data from Iceland are used as an example to study the effect of sales of antidepressants on suicide, disability, hospital admissions and outpatient visits. Results: Sales of antidepressants increased from 8.4 daily defined doses per 1000 inhabitants per day in 1975 to 72.7 in 2000, which is a user prevalence of 8.7% for the adult population. Suicide rates fluctuated during 1950–2000 but did not show any definite trend. Rates for outpatient visits increased slightly over the period 1989–2000 and admission rates increased even more. The prevalence of disability due to depressive and anxiety disorders has not decreased over the past 25 years. Conclusions: The dramatic increase in the sales of antidepressants has not had any marked impact on the selected public health measures. Obviously, better treatment for depressive disorders is still needed in order to reduce the burden caused by them.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Analysis of Count Data
Cameron, A. C., & Trivedi, P. K. (2013) · doi:10.1017/cbo9781139013567 · Cited by 6,640
Changes in public attitudes to depression during the Defeat Depression Campaign
Paykel, E. S., Hart, D., & Priest, R. G. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.6.519 · Cited by 389
BEBBINGTON, P. E., DUNN, G., JENKINS, R., LEWIS, G., BRUGHA, T., FARRELL, M., & MELTZER, H. (1998) · Psychological Medicine · doi:10.1017/s0033291797006077 · Cited by 330
Cited by
Suicide Prevention Strategies: A Systematic Review
Mann, J. J., Apter, A., Bertolote, J., Beautrais, A., Currier, D., Haas, A., Hegerl, U., Lonnqvist, J., Malone, K., Marusic, A., et al. (2005) · JAMA · doi:10.1001/jama.294.16.2064 · Cited by 2,852
The Relationship Between Antidepressant Medication Use and Rate of Suicide
Gibbons, R. D., Hur, K., Bhaumik, D. K., & Mann, J. J. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.165 · Cited by 393
Akiskal, H. S., Benazzi, F., Perugi, G., & Rihmer, Z. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.12.004 · Cited by 348
Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management
Cheung, A. H., Zuckerbrot, R. A., Jensen, P. S., Ghalib, K., Laraque, D., Stein, R. E. K., & and the GLAD-PC Steering Group (2007) · Pediatrics · doi:10.1542/peds.2006-1395 · Cited by 336
Angst, J., Angst, F., Gerber-Werder, R., & Gamma, A. (2005) · Archives of Suicide Research · doi:10.1080/13811110590929488 · Cited by 318
Moore, M., Yuen, H. M., Dunn, N., Mullee, M. A., Maskell, J., & Kendrick, T. (2009) · BMJ · doi:10.1136/bmj.b3999 · Cited by 287
Course of illness in depressive and bipolar disorders: Naturalistic study, 1994–1999
Kessing, L. V., Hansen, M. G., & Andersen, P. K. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.5.372 · Cited by 191
Indications for antidepressant drug prescribing in general practice in the Netherlands
Gardarsdottir, H., Heerdink, E. R., van Dijk, L., & Egberts, A. C. G. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.07.003 · Cited by 170
“…done on antidepressant drug use (Bingefors et al., 1996; Joffe et al., 2001; Hemels et al., 2002; Barbui et al., 2003; Hansen et al., 2003; Rahimtoola et al., 2003; Helgason et al., 2004; Meijer et al., 2004) it is of interest to investigate the indications for antidepressant drug prescription.”
BackgroundAntidepressant Utilization and Suicide in Europe: An Ecological Multi-National Study
Gusmão, R., Quintão, S., McDaid, D., Arensman, E., Van Audenhove, C., Coffey, C., Värnik, A., Värnik, P., Coyne, J., & Hegerl, U. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066455 · Cited by 136
“In order to assess the consistency of the GLMM results, we also performed a Poisson regression, an approach used in a number of previous studies [55–57].”
MethodTrends in service use and treatment for mental disorders in adults throughout Great Britain
Brugha, T. S., Bebbington, P. E., Singleton, N., Melzer, D., Jenkins, R., Lewis, G., Farrell, M., Bhugra, D., Lee, A., & Meltzer, H. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.5.378 · Cited by 114
“For example, the effect of a ninefold increase in antidepressant sales over the years 1975 to 2000 in Iceland was not associated with reductions in suicide rates or out-patient visits (Helgason et al, 2004).”
BackgroundAntidepressants and Suicide Risk: A Comprehensive Overview
Pompili, M., Serafini, G., Innamorati, M., Ambrosi, E., Giordano, G., Girardi, P., Tatarelli, R., & Lester, D. (2010) · Pharmaceuticals · doi:10.3390/ph3092861 · Cited by 53
Exposure to Antidepressant Medications and Suicide Attempts in Adult Depressed Inpatients
Olmer, A., Iancu, I., & Strous, R. D. (2012) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0b013e318257c7e7 · Cited by 7
“Whereas some nationwide trend studies showed no correlation between increased rates of SSRI prescriptions and changes in suicide rates (Helgason et al., 2004; Zahl et al., 2010), other studies found an inverse relation between rates of SSRI prescriptions and changes in suicide rates (Hall et al.,…”
ResultGunnarsdottir, O. S., & Rafnsson, V. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-034590 · Cited by 4
Metadata
- Authors
- Helgason, T., Tómasson, H., & Zoëga, T.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 2004-02
- Volume
- 184
- Issue
- 2
- Pages
- 157-162
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2133451385
- Cited by
- 116
- References
- 3
- FWCI
- 25.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.